Amgen實時圖表

金融工具基礎知識

Weekly Search
Weekly
Daily
日期 關閉 更改 更改(%): 開倉

Amgen 新聞

盧昕穎 2025 Oct 25, 00:00

九月消費者物價指數通膨數據與聯準會展望:深度解析

許景桓 2025 Oct 25, 00:00

摩根大通:聯準會降息期望下,股市可能對高CPI數據不以為意

林芷柔 2025 Oct 25, 00:00

全球央行降息:洞悉市場趨勢與投資策略

張瑋庭 2025 Oct 24, 00:00

特斯拉Q3財報:利潤下滑、馬斯克薪酬爭議與AI轉型

張瑋庭 2025 Oct 24, 00:00

油價因供應擔憂飆升,戰略儲備補充計畫啟動

黃達傑 2025 Oct 09, 16:00

臺灣值得關注的加密貨幣:比特幣(BTC)、以太坊(ETH)、索拉納(Solana,SOL)、零幣(Zcash,ZEC)

黃達傑 2025 Sep 29, 16:00

NIO 股票預測:NIO 今天下跌 5%,未來會怎樣?

黃達傑 2025 Sep 27, 16:00

比特幣價格預測:如何在台灣購買比特幣?

黃達傑 2025 Sep 23, 16:00

Fintech 股票值得關注:Nu Holdings(NU)股票、SOFI 股票

黃達傑 2025 Sep 21, 16:00

QBTS 股票今天上漲 11%:D-Wave Quantum Inc. 發生了什麼事?

最新新聞

顯示更多
許景桓 2025 Oct 25, 00:00

川普對俄政策突變:盧比歐的影響與後果

盧昕穎 2025 Oct 25, 00:00

全球市場回顧:黃金劇烈震盪與科技股勁揚,經濟前景充滿變數

盧昕穎 2025 Oct 25, 00:00

九月消費者物價指數數據:通膨阻力、關稅影響與聯準會降息預期

陳昊然 2025 Oct 25, 00:00

駕馭AI熱潮:Nvidia估值飆升之際的投資策略

林芷柔 2025 Oct 25, 00:00

第四季基金經理趨於謹慎:聚焦人工智慧、通膨與貨幣政策

張瑋庭 2025 Oct 25, 00:00

美國政府關門恐影響十月通膨數據發布

陳昊然 2025 Oct 24, 00:00

美歐關係:俄羅斯制裁在貿易緊張下促成團結

張瑋庭 2025 Oct 24, 00:00

日本央行警告:日本股市過熱,美國貿易政策存在風險

聯絡方式

點差

1.83

點差(%)

0.6288 %

槓桿

1:10

隔夜利息(買入)

-0.0597 %

隔夜利息(賣出)

-0.0292 %

貨幣

USD

交易時間

市場關閉

星期一

13:31 - 19:59

星期二

13:31-19:59

星期三

13:31-19:59

星期四

13:31-19:59

星期五

13:31-19:59

分析與統計

開倉

---

上一次平倉

---

52 週高點/低點

--- – ---

市值

159344345088

流通股份

538361851

收益日期(下一個)

1999-11-22

現金殖利率 

2025-09-12

除息日

2025-08-22

遠期年股息率

9.52

遠期年現金殖利率

0.0325

每股盈餘

12.24

了解有關此金融工具的詳細資訊

Amgen Amgen Inc
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

相關工具

資產
出售
購買
更改(%):
查看所有金融工具

最新教育文章

顯示更多
黃達傑 2025 Oct 13, 16:00

Palantir(PLTR)股價預測:PLTR暴跌5%,Palantir股價會再度飆升嗎?

黃達傑 2025 Oct 13, 16:00

Nvidia(NVDA)股價今日走高:2026年目標價是多少?

黃達傑 2025 Oct 10, 16:00

XRP價格預測:XRP會在一年內達到4美元嗎?

Trustpilot